Sentences with phrase «sma follow»

Complaints that an advertising campaign for SMA Follow - on Milk made misleading claims that it is the best alternative to breast milk have been upheld by the UK Advertising Standards Authority (ASA).

«Because we did not see evidence that SMA Follow - on Milk was the best alternative to breast milk once breastfeeding had stopped, or that it was superior to other follow - on milk, we concluded that the ads were misleading on these grounds,» said the ASA decision.

In a ruling published today it warns Pfizer not to repeat the advertisements after finding: «the ads misleadingly implied that follow - on milk was the best alternative to breast milk» and «the ads misleading implied that SMA Follow - on milk was superior to other follow - on milks».

«Because we did not see evidence that SMA Follow - on Milk was the best alternative to breast milk once breastfeeding had stopped, or that it was superior to other follow - on milk, we concluded that the ads were misleading on these grounds.»

Nestlé has capitalised on Danone's claimed shortage by stating it has no such problems with its SMA brand and this week launched a prominent discount promotion on its SMA follow - on formula in Sainsbury supermarkets (left).

The ASA ruling states: «the ads misleading implied that SMA Follow - on milk was superior to other follow - on milks».

The application of these compounds and technology in SMA follows on the work of Christian Lorson, PhD, Assistant Professor of Veterinary Pathobiology at the University of Missouri, who observed that certain compounds could improve the stability and distribution of the abnormal SMN2 protein in vitro, and proposed that such changes could be harnessed to modulate disease severity in SMA.

Not exact matches

Talking of which, wouldn't it be wonderful to see manufacturers of cleaning products following SMA's lead, dragging themselves out of the 1950s, and showing dads beaming with pride at their spotless kitchens?

The public - facing marketing strategy follows Nestlé's recruitment of a national network of SMA Clinical Representatives, whose job description gives their responsibility as securing «brand endorsement» from health professionals.

Nestlé's aggressive baby milk marketing practices are ever more obvious in the UK following its takeover of the SMA formula brand in 2012.

That this House is concerned that the provisions of the Infant Formula and Follow - on Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to cFollow - on Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to cfollow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to comply.

When Pfizer owned the SMA brand, Baby Milk Action won a case at the Advertising Standards Authority proving its claim that it was the «best» follow - on formula could not be substantiated (see: SMA formula NOT «the best milk after Kate's» ASA ruling finds).

Baby Milk Action press release 8 September 2015 Nestlé's aggressive baby milk marketing practices are ever more obvious in the UK following its takeover of the SMA formula brand in 2012.

«With Nestlé's entry into the UK market following its takeover of Pfizer Nutrition / Wyeth and the SMA formula brand, we are seeing the more aggressive marketing practices it uses around the world appearing here.

We are finding Danone is becoming more aggressive in the UK, perhaps due to Nestlé's entry into the UK market following the completion of its takeover of Pfizer Nutrition / Wyeth and the SMA brand of formula (we have a Say NO to Nestlé campaign).

Nestlé (this includes Good Start, SMA, Follow - Up, Follow - Up Soy, Alsoy, Nursoy, Nestlé Baby Cereal), Nan, Lactogen, Beba, Nestogen, Cérélac, Neslac, Nestum, Guigoz, Gerber, Gerber Graduates.

Following Nestlé's entry into the UK and Irish formula markets in December 2012, when it finalised its takeover of Pfizer Nutrition / Wyeth and the SMA brand, we are starting to see more aggressive baby milk marketing practices, both from Nestlé and...

Following Nestlé's entry into the UK and Irish formula markets in December 2012, when it finalised its takeover of Pfizer Nutrition / Wyeth and the SMA brand, we are starting to see more aggressive baby milk marketing practices, both from Nestlé and its main competitor, Danone.

Baby Milk Action press release 15 December 2014 Change.org petition campaign calling for customers to be informed they were misled Nestlé has finally removed some misleading claims from its website for SMA Toddler Milk following complaints by Baby Milk Action...

(This is obvious in the UK following Nestlé's takeover of Pfizer Nutrition and the SMA brand (ref.

Nestlé has finally removed some misleading claims from its website for SMA Toddler Milk following complaints by Baby Milk Action to the Advertising Standards Authority (ASA), but the ASA has done virtually nothing to highlight the outcome if its investigation.

Tesco is trying to clear existing stocks of Nestle SMA infant formula with point - of - sale promotions that violate the Infant Formula and Follow - on Formula Regulations (2007).

The JACEI report states, «UK television advertisements for Nestlé's SMA Toddler Milk (for one year and above) would appear to conform to the UK guidelines on the advertising of follow - on formula, satisfying provisions in the guidelines that seek to avoid the risk of confusion between infant formula and follow - on formula.»

Pfizer / Wyeth has another ruling against it today from the Advertising Standards Authority (ASA) following a complaint brought by Baby Milk Action, this time against an email campaign for its SMA brand of formula.

Update 15 December 2014: Nestle's forced to remove misleading SMA claims following...

Following complaints by Baby Milk Action and other groups and individuals, the Advertising Standards Authority (ASA) has ruled the answer is NOT SMA formula.

Update 15 December 2014: Nestle's forced to remove misleading SMA claims following Baby Milk Action complaint

That has only happened once since the first version of Infant Formula and Follow - on Formula Regulations were introduced in 1995 (Birmingham Trading Standards won a case against illegal advertising of SMA infant formula in 2003).

Nestlé has entered the UK market following its takeover of Pfizer Nutrition / Wyeth and the SMA formula brand.

When Nestlé entered the UK market with the takeover of the SMA brand in 2012, it recruited a network of well - paid Clinical Representatives (who also gain bonuses), with the stated responsibilities as follows:

In appreciation of our community of members who support our mission, SMA offers the following special membership benefits.

The following is a complete list of SMA State Coordinators located in the United States, organized by state.

The following professionals have joined our SMA community.

The SMA model pig was created using a gene therapy approach by knocking down the levels of pig SMN, followed by treatment with human SMN at early and late time points.

Isis acknowledges support from the following organizations for ISIS - SMNRx: Muscular Dystrophy Association, SMA Foundation, Families of SMA and intellectual property licensed from Cold Spring Harbor Laboratory and the University of Massachusetts Medical School.

Isis acknowledges support from the following organizations for this program: Muscular Dystrophy Association, SMA Foundation, Families of SMA and intellectual property licensed from Cold Spring Harbor Laboratory and the University of Massachusetts Medical School.

SMA children in the 3 mg, 6 mg and 9 mg cohorts achieved mean increases in HFMSE scores of 1.5, 2.3 and 3.7 points, respectively, nine months following the first dose of ISIS - SMNRx.

This project resulted in the publication of the Consensus Statement on Standard of Care for SMA in Child Neurology and was followed up by the development and publication of the Family Guide to the Consensus Statement, available in both English and Spanish.

Spinal Muscular Atrophy with Respiratory Distress (SMARD) is a very rare recessive form of Spinal Muscular Atrophy (SMA) that typically presents as acute respiratory failure between 6 weeks to 6 months of age followed by a progressive motor paralysis.

Tie is now turning the focus of this study to follow - up observations with JCMT (e.g. POL - 2) as well as many other telescopes (e.g., ALMA, SMA, NRO 45 - m, KVN, FAST 500m...).

SMA Foundation Patient Advisory Board member Amelie Gubitz finished the discussion by suggesting these issues be followed in natural history studies.

Part two is an open - label, single - arm study in approximately 40 infants with Type I SMA for 24 months, followed by an open - label extension.

Currently, our investment strategies are managed at the following regional broker - dealers and institutional wire house SMA platforms.

The 50 - sma caught the falling index on the initial drop, but couldn't hold it the following day.

Most of my trend following systems are in cash and my primary signal has been waiting for stocks to break back over the 200 day SMA like $ SMH, $ FB, and $ AAPL.

Trend following signals try to go in the direction of the long term trend by using long term moving averages like the 200 day SMA breaks as buy or sell signals, or all - time highs or lows to enter longs or shorts.

When the S&P 500 closes below its 10 month SMA, hedge the portfolio beginning the following month.

The 100 SMA is still below the longer - term trendline, but the two are getting closer showing bullish sentiment may follow.

The immediate support is seen at $ 130,00, it is followed by $ 134.00 (50 - SMA on the hourly chart) and $ 140.00.

It is followed by 50 - SMA at $ 0.5145.